Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 1037 entries
Sorted by: Best Match Show Resources per page
Current Status of Fluoroquinolone Use for Treatment of Tuberculosis in a Tertiary Care Hospital in Korea.

Tuberculosis and respiratory diseases

Kang BH, Jo KW, Shim TS.
PMID: 28416954
Tuberc Respir Dis (Seoul). 2017 Apr;80(2):143-152. doi: 10.4046/trd.2017.80.2.143. Epub 2017 Mar 31.

BACKGROUND: Fluoroquinolones are considered important substitutes for the treatment of tuberculosis. This study investigates the current status of fluoroquinolone for the treatment of tuberculosis.METHODS: In 2009, a retrospective analysis was performed at one tertiary referral center for 953 patients...

Cite
Kang BH, Jo KW, Shim TS. Current Status of Fluoroquinolone Use for Treatment of Tuberculosis in a Tertiary Care Hospital in Korea. Tuberc Respir Dis (Seoul). 2017;80(2):143-152doi: 10.4046/trd.2017.80.2.143.
Kang, B. H., Jo, K. W., & Shim, T. S. (2017). Current Status of Fluoroquinolone Use for Treatment of Tuberculosis in a Tertiary Care Hospital in Korea. Tuberculosis and respiratory diseases, 80(2), 143-152. https://doi.org/10.4046/trd.2017.80.2.143
Kang, Bo Hyoung, et al. "Current Status of Fluoroquinolone Use for Treatment of Tuberculosis in a Tertiary Care Hospital in Korea." Tuberculosis and respiratory diseases vol. 80,2 (2017): 143-152. doi: https://doi.org/10.4046/trd.2017.80.2.143
Kang BH, Jo KW, Shim TS. Current Status of Fluoroquinolone Use for Treatment of Tuberculosis in a Tertiary Care Hospital in Korea. Tuberc Respir Dis (Seoul). 2017 Apr;80(2):143-152. doi: 10.4046/trd.2017.80.2.143. Epub 2017 Mar 31. PMID: 28416954; PMCID: PMC5392485.
Copy Download .nbib Format: NLM
Feline-transmitted .

International medical case reports journal

Chao SC, Lee CY, Nien CW, Tzeng SH, Lin HY.
PMID: 28860868
Int Med Case Rep J. 2017 Aug 16;10:279-283. doi: 10.2147/IMCRJ.S141710. eCollection 2017.

BACKGROUND: Postoperative endophthalmitis is a dreaded postsurgery complication which may lead to legal blindness. In addition to typical risk factors, some minor episodes may also lead to the occurrence of endophthalmitis. The purpose of the current study was to...

Cite
Chao SC, Lee CY, Nien CW, et al. Feline-transmitted . Int Med Case Rep J. 2017;10:279-283doi: 10.2147/IMCRJ.S141710.
Chao, S. C., Lee, C. Y., Nien, C. W., Tzeng, S. H., & Lin, H. Y. (2017). Feline-transmitted . International medical case reports journal, 10279-283. https://doi.org/10.2147/IMCRJ.S141710
Chao, Shih-Chun, et al. "Feline-transmitted ." International medical case reports journal vol. 10 (2017): 279-283. doi: https://doi.org/10.2147/IMCRJ.S141710
Chao SC, Lee CY, Nien CW, Tzeng SH, Lin HY. Feline-transmitted . Int Med Case Rep J. 2017 Aug 16;10:279-283. doi: 10.2147/IMCRJ.S141710. eCollection 2017. PMID: 28860868; PMCID: PMC5566369.
Copy Download .nbib Format: NLM
Autoimmune hemolytic anemia induced by levofloxacin.

Case reports in infectious diseases

Sheikh-Taha M, Frenn P.
PMID: 25024854
Case Rep Infect Dis. 2014;2014:201015. doi: 10.1155/2014/201015. Epub 2014 Jun 12.

Drug-induced autoimmune hemolytic anemia is a rare condition. We report the case of a 32-year-old white female who presented to the emergency department with generalized fatigue, fever, and jaundice. The patient reported using levofloxacin few days prior to presentation...

Cite
Sheikh-Taha M, Frenn P. Autoimmune hemolytic anemia induced by levofloxacin. Case Rep Infect Dis. 2014;2014:201015doi: 10.1155/2014/201015.
Sheikh-Taha, M., & Frenn, P. (2014). Autoimmune hemolytic anemia induced by levofloxacin. Case reports in infectious diseases, 2014201015. https://doi.org/10.1155/2014/201015
Sheikh-Taha, Marwan, and Frenn, Pascale. "Autoimmune hemolytic anemia induced by levofloxacin." Case reports in infectious diseases vol. 2014 (2014): 201015. doi: https://doi.org/10.1155/2014/201015
Sheikh-Taha M, Frenn P. Autoimmune hemolytic anemia induced by levofloxacin. Case Rep Infect Dis. 2014;2014:201015. doi: 10.1155/2014/201015. Epub 2014 Jun 12. PMID: 25024854; PMCID: PMC4082951.
Copy Download .nbib Format: NLM
[Not Available].

Revista brasileira de hematologia e hemoterapia

Lopes LA, Veroneze I, Burgardt CI, Stier CJ.
PMID: 25030670
Rev Bras Hematol Hemoter. 2014 Jan-Feb;36(1):35-42. doi: 10.5581/1516-8484.20140011. Epub 2014 Mar 12.

No abstract available.

Cite
Lopes LA, Veroneze I, Burgardt CI, et al. Prophylaxis with levofloxacin: impact on bacterial susceptibility and epidemiology in a hematopoietic stem cell transplant unit. [Not Available]. Rev Bras Hematol Hemoter. 2014;36(1):35-42doi: 10.5581/1516-8484.20140011.
Lopes, L. A., Veroneze, I., Burgardt, C. I., & Stier, C. J. (2014). Prophylaxis with levofloxacin: impact on bacterial susceptibility and epidemiology in a hematopoietic stem cell transplant unit. [Not Available]. Revista brasileira de hematologia e hemoterapia, 36(1), 35-42. https://doi.org/10.5581/1516-8484.20140011
Lopes, Livia Amaral Alonso, et al. "Prophylaxis with levofloxacin: impact on bacterial susceptibility and epidemiology in a hematopoietic stem cell transplant unit." [Not Available]. Revista brasileira de hematologia e hemoterapia vol. 36,1 (2014): 35-42. doi: https://doi.org/10.5581/1516-8484.20140011
Lopes LA, Veroneze I, Burgardt CI, Stier CJ. Prophylaxis with levofloxacin: impact on bacterial susceptibility and epidemiology in a hematopoietic stem cell transplant unit. [Not Available]. Rev Bras Hematol Hemoter. 2014 Jan-Feb;36(1):35-42. doi: 10.5581/1516-8484.20140011. Epub 2014 Mar 12. Portuguese. PMID: 25030670.
Copy Download .nbib Format: NLM
Multicenter Study of Antibiotic Resistance Profile of H. pylori and Distribution of CYP2C19 Gene Polymorphism in Rural Population of Chongqing, China.

Gastroenterology research and practice

Han R, Lu H, Jiang MW, Tan KW, Peng Z, Hu JL, Fang DC, Lan CH, Wu XL.
PMID: 27247569
Gastroenterol Res Pract. 2016;2016:8547686. doi: 10.1155/2016/8547686. Epub 2016 May 09.

This study was to investigate the antibiotic resistance profile of H. pylori and the distribution of CYP2C19 gene polymorphism in rural population of Chongqing, China. 214 and 111 strains of H. pylori were isolated from rural and urban patients,...

Cite
Han R, Lu H, Jiang MW, et al. Multicenter Study of Antibiotic Resistance Profile of H. pylori and Distribution of CYP2C19 Gene Polymorphism in Rural Population of Chongqing, China. Gastroenterol Res Pract. 2016;2016:8547686doi: 10.1155/2016/8547686.
Han, R., Lu, H., Jiang, M. W., Tan, K. W., Peng, Z., Hu, J. L., Fang, D. C., Lan, C. H., & Wu, X. L. (2016). Multicenter Study of Antibiotic Resistance Profile of H. pylori and Distribution of CYP2C19 Gene Polymorphism in Rural Population of Chongqing, China. Gastroenterology research and practice, 20168547686. https://doi.org/10.1155/2016/8547686
Han, Ran, et al. "Multicenter Study of Antibiotic Resistance Profile of H. pylori and Distribution of CYP2C19 Gene Polymorphism in Rural Population of Chongqing, China." Gastroenterology research and practice vol. 2016 (2016): 8547686. doi: https://doi.org/10.1155/2016/8547686
Han R, Lu H, Jiang MW, Tan KW, Peng Z, Hu JL, Fang DC, Lan CH, Wu XL. Multicenter Study of Antibiotic Resistance Profile of H. pylori and Distribution of CYP2C19 Gene Polymorphism in Rural Population of Chongqing, China. Gastroenterol Res Pract. 2016;2016:8547686. doi: 10.1155/2016/8547686. Epub 2016 May 09. PMID: 27247569; PMCID: PMC4876203.
Copy Download .nbib Format: NLM
Emerging ST121/agr4 community-associated methicillin-resistant Staphylococcus aureus (MRSA) with strong adhesin and cytolytic activities: trigger for MRSA pneumonia and fatal aspiration pneumonia in an influenza-infected elderly.

New microbes and new infections

Wan TW, Tomita Y, Saita N, Konno K, Iwao Y, Hung WC, Teng LJ, Yamamoto T.
PMID: 27358743
New Microbes New Infect. 2016 May 26;13:17-21. doi: 10.1016/j.nmni.2016.05.011. eCollection 2016 Sep.

The pathogenesis of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) pneumonia in influenza-infected elderly individuals has not yet been elucidated in detail. In the present study, a 92-year-old man infected with influenza developed CA-MRSA pneumonia. His CA-MRSA was an emerging type,...

Cite
Wan TW, Tomita Y, Saita N, et al. Emerging ST121/agr4 community-associated methicillin-resistant Staphylococcus aureus (MRSA) with strong adhesin and cytolytic activities: trigger for MRSA pneumonia and fatal aspiration pneumonia in an influenza-infected elderly. New Microbes New Infect. 2016;13:17-21doi: 10.1016/j.nmni.2016.05.011.
Wan, T. W., Tomita, Y., Saita, N., Konno, K., Iwao, Y., Hung, W. C., Teng, L. J., & Yamamoto, T. (2016). Emerging ST121/agr4 community-associated methicillin-resistant Staphylococcus aureus (MRSA) with strong adhesin and cytolytic activities: trigger for MRSA pneumonia and fatal aspiration pneumonia in an influenza-infected elderly. New microbes and new infections, 1317-21. https://doi.org/10.1016/j.nmni.2016.05.011
Wan, T-W, et al. "Emerging ST121/agr4 community-associated methicillin-resistant Staphylococcus aureus (MRSA) with strong adhesin and cytolytic activities: trigger for MRSA pneumonia and fatal aspiration pneumonia in an influenza-infected elderly." New microbes and new infections vol. 13 (2016): 17-21. doi: https://doi.org/10.1016/j.nmni.2016.05.011
Wan TW, Tomita Y, Saita N, Konno K, Iwao Y, Hung WC, Teng LJ, Yamamoto T. Emerging ST121/agr4 community-associated methicillin-resistant Staphylococcus aureus (MRSA) with strong adhesin and cytolytic activities: trigger for MRSA pneumonia and fatal aspiration pneumonia in an influenza-infected elderly. New Microbes New Infect. 2016 May 26;13:17-21. doi: 10.1016/j.nmni.2016.05.011. eCollection 2016 Sep. PMID: 27358743; PMCID: PMC4917487.
Copy Download .nbib Format: NLM
Duodenal ulcer promoting gene 1 (dupA1) is associated with A2147G clarithromycin-resistance mutation but not interleukin-8 secretion from gastric mucosa in Iraqi patients.

New microbes and new infections

Hussein NR, Tunjel I, Majed HS, Yousif ST, Aswad SI, Assafi MS.
PMID: 26042186
New Microbes New Infect. 2015 Mar 04;6:5-10. doi: 10.1016/j.nmni.2015.02.005. eCollection 2015 Jul.

Helicobacter pylori causes peptic ulceration and gastric adenocarcinoma. The aims were to study the influence of dupA1 positivity upon interleukin-8 (IL-8) secretion from gastric mucosa and determine the prevalence of mutations responsible for clarithromycin and fluoroquinolone resistance. DNA was...

Cite
Hussein NR, Tunjel I, Majed HS, et al. Duodenal ulcer promoting gene 1 (dupA1) is associated with A2147G clarithromycin-resistance mutation but not interleukin-8 secretion from gastric mucosa in Iraqi patients. New Microbes New Infect. 2015;6:5-10doi: 10.1016/j.nmni.2015.02.005.
Hussein, N. R., Tunjel, I., Majed, H. S., Yousif, S. T., Aswad, S. I., & Assafi, M. S. (2015). Duodenal ulcer promoting gene 1 (dupA1) is associated with A2147G clarithromycin-resistance mutation but not interleukin-8 secretion from gastric mucosa in Iraqi patients. New microbes and new infections, 65-10. https://doi.org/10.1016/j.nmni.2015.02.005
Hussein, N R, et al. "Duodenal ulcer promoting gene 1 (dupA1) is associated with A2147G clarithromycin-resistance mutation but not interleukin-8 secretion from gastric mucosa in Iraqi patients." New microbes and new infections vol. 6 (2015): 5-10. doi: https://doi.org/10.1016/j.nmni.2015.02.005
Hussein NR, Tunjel I, Majed HS, Yousif ST, Aswad SI, Assafi MS. Duodenal ulcer promoting gene 1 (dupA1) is associated with A2147G clarithromycin-resistance mutation but not interleukin-8 secretion from gastric mucosa in Iraqi patients. New Microbes New Infect. 2015 Mar 04;6:5-10. doi: 10.1016/j.nmni.2015.02.005. eCollection 2015 Jul. PMID: 26042186; PMCID: PMC4442689.
Copy Download .nbib Format: NLM
Sensitivity of polymerase chain reaction to determine chlamydia trachomatis eradication rate with levofloxacin therapy in patients with chlamydial cervicitis.

Current therapeutic research, clinical and experimental

Mikamo H, Ninomiya M, Tamaya T.
PMID: 24944386
Curr Ther Res Clin Exp. 2003 Jun;64(6):375-7. doi: 10.1016/S0011-393X(03)00088-2.

BACKGROUND: For the treatment of chlamydial cervicitis, a 7- to 14-day regimen with appropriate antibacterial agents (eg, macrolides, tetracycline, fluoroquinolones) has been recommended. Many clinicians in Japan have determined the eradication rate of cervical Chlamydia trachomatis by polymerase chain...

Cite
Mikamo H, Ninomiya M, Tamaya T. Sensitivity of polymerase chain reaction to determine chlamydia trachomatis eradication rate with levofloxacin therapy in patients with chlamydial cervicitis. Curr Ther Res Clin Exp. 2003;64(6):375-7doi: 10.1016/S0011-393X(03)00088-2.
Mikamo, H., Ninomiya, M., & Tamaya, T. (2003). Sensitivity of polymerase chain reaction to determine chlamydia trachomatis eradication rate with levofloxacin therapy in patients with chlamydial cervicitis. Current therapeutic research, clinical and experimental, 64(6), 375-7. https://doi.org/10.1016/S0011-393X(03)00088-2
Mikamo, Hiroshige, et al. "Sensitivity of polymerase chain reaction to determine chlamydia trachomatis eradication rate with levofloxacin therapy in patients with chlamydial cervicitis." Current therapeutic research, clinical and experimental vol. 64,6 (2003): 375-7. doi: https://doi.org/10.1016/S0011-393X(03)00088-2
Mikamo H, Ninomiya M, Tamaya T. Sensitivity of polymerase chain reaction to determine chlamydia trachomatis eradication rate with levofloxacin therapy in patients with chlamydial cervicitis. Curr Ther Res Clin Exp. 2003 Jun;64(6):375-7. doi: 10.1016/S0011-393X(03)00088-2. PMID: 24944386; PMCID: PMC4053008.
Copy Download .nbib Format: NLM
Efficacy of Intravitreal Levofloxacin 0.5% Ophthalmic Solution in Treating Pseudomonas Aeruginosa Endophthalmitis on a Rabbit Model.

Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)

Aziza Y, Kodrat E, Saharman YR, Setiabudy R, Susiyanti M, Sjamsoe S.
PMID: 26108113
Asia Pac J Ophthalmol (Phila). 2013 May-Jun;2(3):199-205. doi: 10.1097/APO.0b013e3182970cc9.

PURPOSE: To evaluate the efficacy of intravitreal levofloxacin 0.5% ophthalmic solution as treatment of Pseudomonas aeruginosa endophthalmitis in a rabbit model.DESIGN: This is a parallel randomized experimental study.METHODS: Twenty-six New Zealand white rabbits were enrolled. P. aeruginosa was inoculated...

Cite
Aziza Y, Kodrat E, Saharman YR, et al. Efficacy of Intravitreal Levofloxacin 0.5% Ophthalmic Solution in Treating Pseudomonas Aeruginosa Endophthalmitis on a Rabbit Model. Asia Pac J Ophthalmol (Phila). 2013;2(3):199-205doi: 10.1097/APO.0b013e3182970cc9.
Aziza, Y., Kodrat, E., Saharman, Y. R., Setiabudy, R., Susiyanti, M., & Sjamsoe, S. (2013). Efficacy of Intravitreal Levofloxacin 0.5% Ophthalmic Solution in Treating Pseudomonas Aeruginosa Endophthalmitis on a Rabbit Model. Asia-Pacific journal of ophthalmology (Philadelphia, Pa.), 2(3), 199-205. https://doi.org/10.1097/APO.0b013e3182970cc9
Aziza, Yulia, et al. "Efficacy of Intravitreal Levofloxacin 0.5% Ophthalmic Solution in Treating Pseudomonas Aeruginosa Endophthalmitis on a Rabbit Model." Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) vol. 2,3 (2013): 199-205. doi: https://doi.org/10.1097/APO.0b013e3182970cc9
Aziza Y, Kodrat E, Saharman YR, Setiabudy R, Susiyanti M, Sjamsoe S. Efficacy of Intravitreal Levofloxacin 0.5% Ophthalmic Solution in Treating Pseudomonas Aeruginosa Endophthalmitis on a Rabbit Model. Asia Pac J Ophthalmol (Phila). 2013 May-Jun;2(3):199-205. doi: 10.1097/APO.0b013e3182970cc9. PMID: 26108113.
Copy Download .nbib Format: NLM
Antimicrobial use at a multi-disciplinary hospital.

The International journal of risk & safety in medicine

Khudaibergenova MS.
PMID: 26639689
Int J Risk Saf Med. 2015;27:S13-4. doi: 10.3233/JRS-150671.

BACKGROUND: The problem of antimicrobial resistance has become topical and alarming all over the world, including Kazakhstan. Nosocomial strains of microorganisms are widespread, being resistant to the majority of available antimicrobials. This results in longer periods of hospital stay,...

Cite
Khudaibergenova MS. Antimicrobial use at a multi-disciplinary hospital. Int J Risk Saf Med. 2015;27:S13-4doi: 10.3233/JRS-150671.
Khudaibergenova, M. S. (2015). Antimicrobial use at a multi-disciplinary hospital. The International journal of risk & safety in medicine, 27S13-4. https://doi.org/10.3233/JRS-150671
Khudaibergenova, M S. "Antimicrobial use at a multi-disciplinary hospital." The International journal of risk & safety in medicine vol. 27 (2015): S13-4. doi: https://doi.org/10.3233/JRS-150671
Khudaibergenova MS. Antimicrobial use at a multi-disciplinary hospital. Int J Risk Saf Med. 2015;27:S13-4. doi: 10.3233/JRS-150671. PMID: 26639689.
Copy Download .nbib Format: NLM
Multicystic dysplastic kidney complicated by pyelonephritis.

The American journal of case reports

Cooper CJ, Said S, Khalillullah S, Salameh HJ, Hernandez GT.
PMID: 24349603
Am J Case Rep. 2013 Oct 14;14:412-5. doi: 10.12659/AJCR.889557. eCollection 2013.

PATIENT: Female, 21 FINAL DIAGNOSIS: Multicystic Dysplastic Kidney Disease complicated by pyelonephritis Symptoms: Left flank pain (CVAT) • dysuria • feverMEDICATION: Levofloxacin Clinical Procedure: Dimercaptosuccinic acid scan • voiding cystouretrogram Specialty: Nephrology.OBJECTIVE: Rare disease.BACKGROUND: Multicystic dysplastic kidney (MCDK) is...

Cite
Cooper CJ, Said S, Khalillullah S, et al. Multicystic dysplastic kidney complicated by pyelonephritis. Am J Case Rep. 2013;14:412-5doi: 10.12659/AJCR.889557.
Cooper, C. J., Said, S., Khalillullah, S., Salameh, H. J., & Hernandez, G. T. (2013). Multicystic dysplastic kidney complicated by pyelonephritis. The American journal of case reports, 14412-5. https://doi.org/10.12659/AJCR.889557
Cooper, Chad J, et al. "Multicystic dysplastic kidney complicated by pyelonephritis." The American journal of case reports vol. 14 (2013): 412-5. doi: https://doi.org/10.12659/AJCR.889557
Cooper CJ, Said S, Khalillullah S, Salameh HJ, Hernandez GT. Multicystic dysplastic kidney complicated by pyelonephritis. Am J Case Rep. 2013 Oct 14;14:412-5. doi: 10.12659/AJCR.889557. eCollection 2013. PMID: 24349603; PMCID: PMC3864172.
Copy Download .nbib Format: NLM
Cost-Effectiveness Analysis of High-Dose Levofloxacin Therapy of Patients With Community-Acquired Pneumonia.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Zaytsev A, Makarevich A.
PMID: 27202050
Value Health. 2014 Nov;17(7):A596. doi: 10.1016/j.jval.2014.08.2058. Epub 2014 Oct 26.

No abstract available.

Cite
Zaytsev A, Makarevich A. Cost-Effectiveness Analysis of High-Dose Levofloxacin Therapy of Patients With Community-Acquired Pneumonia. Value Health. 2014;17(7):A596doi: 10.1016/j.jval.2014.08.2058.
Zaytsev, A., & Makarevich, A. (2014). Cost-Effectiveness Analysis of High-Dose Levofloxacin Therapy of Patients With Community-Acquired Pneumonia. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A596. https://doi.org/10.1016/j.jval.2014.08.2058
Zaytsev, A, and Makarevich, A. "Cost-Effectiveness Analysis of High-Dose Levofloxacin Therapy of Patients With Community-Acquired Pneumonia." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A596. doi: https://doi.org/10.1016/j.jval.2014.08.2058
Zaytsev A, Makarevich A. Cost-Effectiveness Analysis of High-Dose Levofloxacin Therapy of Patients With Community-Acquired Pneumonia. Value Health. 2014 Nov;17(7):A596. doi: 10.1016/j.jval.2014.08.2058. Epub 2014 Oct 26. PMID: 27202050.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 1037 entries